Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancer.
作者信息
Fang Wenfeng, Ma Yuxiang, Yin Jiani C, Zhou Huaqiang, Wang Fufeng, Bao Hua, Wang Ao, Wu Xue, Hong Shaodong, Yang Yunpeng, Huang Yan, Zhao Hongyun, Shao Yang W, Zhang Li
机构信息
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Nanjing Geneseeq Technology Inc., Nanjing, China.
出版信息
Clin Transl Med. 2020 Jan;10(1):331-336. doi: 10.1002/ctm2.8.
Abstract
摘要
Zotero 插件